Login / Signup

Do microplastics impair male dominance interactions in fish? A test of the vector hypothesis.

Ally SwankKadijah BlevinsAbby BourneJessica L Ward
Published in: Ecology and evolution (2022)
Microplastics (MPs) are widespread in aquatic environments and have become a critical environmental issue in recent years due to their adverse impacts on the physiology, reproduction, and survival of aquatic animals. Exposure to MPs also has the potential to induce sub-lethal behavioral changes that can affect individual fitness, but these effects are understudied. Many plastic additives introduced during the manufacture of MPs are known endocrine-disrupting chemicals (EDCs) that mimic the action of natural hormones, alter sexual and competitive behavior, and impair reproductive success in fish. In addition, EDCs and other aquatic contaminants may adhere to MPs in the environment, the latter of which may serve as transport vectors for these compounds (i.e., the vector hypothesis ). In this study, we staged territorial contests between control males, and males exposed to virgin MP particles or to MPs previously immersed in one of two environmentally relevant concentrations of 17-alpha ethinyl estradiol (EE2; 5 ng/L and 25 ng/L) to evaluate the independent and synergistic effects of exposure to MPs and a common environmental estrogen on male-male aggression and competitive territory acquisition in a freshwater fish, Pimephales promelas . Short-term (30 days) dietary exposure to MPs did not impair the ability of males to successfully compete for and obtain a breeding territory. Overall levels of aggression in control and exposed males were also similar across trial series. These results help to fill a critical knowledge gap regarding the direct and indirect (vector-borne) effects of MPs on the reproductive behavior of aquatic vertebrates in freshwater systems.
Keyphrases
  • risk assessment
  • human health
  • emergency department
  • randomized controlled trial
  • clinical trial
  • body composition
  • physical activity
  • estrogen receptor
  • phase iii
  • open label
  • life cycle
  • double blind
  • adverse drug